Chongqing Lummy Pharmaceutical Co.,Ltd. Posted 29 Million Yuan Net Loss in First Quarter of 2022

Chongqing Lummy Pharmaceutical Co.,Ltd. (重庆莱美药业股份有限公司) (300006.SZ) reported a net loss of 29 million yuan in the first quarter of 2022, reversing a net profit of 52 million yuan for the same period in the previous year.

Meanwhile, the company posted 198.7 million yuan in revenue, down 44.8% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 825.9 million yuan in total liabilities, with a liability-to-asset ratio of 27.5%.